Prediction of renal insufficiency in Pima Indians with nephropathy of type 2 diabetes mellitus

被引:19
作者
Goldfarb-Rumyantzev, AS
Pappas, L
机构
[1] Univ Utah, Sch Med, Div Nephrol, Salt Lake City, UT 84112 USA
[2] Univ Utah, Sch Med, Div Hypertens, Salt Lake City, UT 84112 USA
关键词
prediction model; artificial neural network; tree-based model; generalized additive model; Pima Indians; diabetic nephropathy; renal insufficiency; outcome;
D O I
10.1053/ajkd.2002.34503
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: A high prevalence and early onset of type 2 diabetes in Pima Indians is well known. Our objective is to use several statistical models to identify predictors of glomerular filtration rate (GFR) deterioration and develop an algorithm to predict GFR 4 years after the initial evaluation. Methods: All records (n = 86) were randomly assigned to a training set (n = 60) and a testing set (n = 26). Linear regression, generalized additive, tree-based, and artificial neural network models were used to identify predictors of outcome and develop a prediction algorithm. Results: Proteinuria remained the single most important predictor of long-term renal function; other predictors included baseline GFR, blood pressure, plasma renin activity, lipid profile, age, weight/body mass index, and diabetes duration. All four models achieved a good correlation (r = 0.73 to 0.78) between observed and predicted 4-year GFRs on a separate (testing) data set. Best results in predicting the value of GFR were achieved using a tree-based model with six terminal nodes (r = 0.78; root mean squared prediction error = 38.9). The tree-based and generalized additive models achieved high positive (91%) and negative (100%) predictive values in identifying subjects, who developed depressed GFRs in 4 years. An artificial neural network achieved the highest area under the receiver operating characteristic curve (0.91). Conclusion: GFR depression within 4 years can be predicted with a precision that suggests potential clinical utility. A tree-based model with six terminal nodes has shown the best results in predicting the actual value of GFR, whereas an artificial neural network is the model of choice to identify the group of patients that will develop renal insufficiency. (C) 2002 by the National Kidney Foundation, Inc.
引用
收藏
页码:252 / 264
页数:13
相关论文
共 39 条
[11]  
Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302
[12]  
Hastie T.J., 1990, Generalized Additive Models, V1st, DOI DOI 10.1214/SS/1177013604
[13]   Cardiac risk stratification in renal transplantation using a form of artificial intelligence [J].
Heston, TF ;
Norman, DJ ;
Barry, JM ;
Bennett, WM ;
Wilson, RA .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (04) :415-417
[14]   HOW NEURAL NETWORKS LEARN FROM EXPERIENCE [J].
HINTON, GE .
SCIENTIFIC AMERICAN, 1992, 267 (03) :145-151
[15]   THE EFFECTS OF DIETARY-PROTEIN RESTRICTION AND BLOOD-PRESSURE CONTROL ON THE PROGRESSION OF CHRONIC RENAL-DISEASE [J].
KLAHR, S ;
LEVEY, AS ;
BECK, GJ ;
CAGGIULA, AW ;
HUNSICKER, L ;
KUSEK, JW ;
STRIKER, G ;
BUCKALEW, V ;
BURKART, J ;
FURBERG, C ;
FELTS, J ;
MOORE, M ;
ROCCO, H ;
DOLECEK, T ;
WARREN, S ;
BEARDEN, B ;
STARKEY, C ;
HARVEY, J ;
POOLE, D ;
DAHLQUIST, S ;
DOROSHENKO, L ;
BRADHAM, K ;
WEST, D ;
AGOSTINO, J ;
COLE, L ;
BAKER, B ;
HAIRSTON, K ;
BURGOYNE, S ;
LAZARUS, J ;
STEINMAN, T ;
SEIFTER, J ;
DESMOND, M ;
FIORENZO, M ;
CHIAVACCI, A ;
METALIDES, T ;
KORZECRAMIREZ, D ;
GOULD, S ;
PICKETT, V ;
PORUSH, J ;
FAUBERT, P ;
SPITALEWITZ, S ;
FAUBERT, J ;
ZIMMER, G ;
SAUM, D ;
BLOCK, M ;
WOEL, J ;
ROSE, M ;
DENNIS, V ;
SCHWAB, S ;
MINDA, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (13) :877-884
[16]   Risk factors for microalbuminuria in Black Americans with newly diagnosed type 2 diabetes [J].
Kohler, KA ;
McClellan, WM ;
Ziemer, DC ;
Kleinbaum, DG ;
Boring, JR .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (05) :903-913
[17]   Evolution of incipient nephropathy in type 2 diabetes mellitus [J].
Lemley, KV ;
Abdullah, I ;
Myers, BD ;
Meyer, TW ;
Blouch, K ;
Smith, WE ;
Bennett, PH ;
Nelson, RG .
KIDNEY INTERNATIONAL, 2000, 58 (03) :1228-1237
[18]  
Lemley KV, 2000, J AM SOC NEPHROL, V11, P2095, DOI 10.1681/ASN.V11112095
[19]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[20]  
Lewis RJ, 2000, ANN M SOC AC EM MED